Cargando…
Mocetinostat activates Krüppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis
Osteoarthritis (OA) is the most common joint disorder, and disease-modifying OA drugs (DMOADs) represent a major need in OA management. Krüppel-like factor 4 (KLF4) is a central transcription factor upregulating regenerative and protective functions in joint tissues. This study was aimed to identify...
Autores principales: | Kawata, Manabu, McClatchy, Daniel B., Diedrich, Jolene K., Olmer, Merissa, Johnson, Kristen A., Yates, John R., Lotz, Martin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544226/ https://www.ncbi.nlm.nih.gov/pubmed/37681413 http://dx.doi.org/10.1172/jci.insight.170513 |
Ejemplares similares
-
RNA-binding proteins that are highly expressed and enriched in healthy cartilage but suppressed in osteoarthritis
por: Swahn, Hannah, et al.
Publicado: (2023) -
Transthyretin deposition promotes progression of osteoarthritis
por: Matsuzaki, Tokio, et al.
Publicado: (2017) -
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
por: Lopez, Gonzalo, et al.
Publicado: (2017) -
Intracellular amyloid toxicity induces oxytosis/ferroptosis regulated cell death
por: Huang, Ling, et al.
Publicado: (2020) -
Interactome analysis illustrates diverse gene regulatory processes associated with LIN28A in human iPS cell-derived neural progenitor cells
por: Yu, Nam-Kyung, et al.
Publicado: (2021)